In addition, as CA125 and HE4 are physiologically present in serum even in healthy persons, cut-off determination to differentiate between “no active cancer” and “still active cancer”, or “significant reduction in activity of cancer” and “non-significant reduction in activity of cancer” in patients undergoing cancer treatment is challenging. Here, WFDC2 is linked to cancer.